Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Direct Oral Anticoagulants in Chronic Liver Disease
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Direct Oral Anticoagulants in Chronic Liver Disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Direct Oral Anticoagulants
100%
Chronic Liver Disease
100%
Anticoagulants
25%
Clinical Trials
16%
Moderate to Severe
16%
MEDLINE
8%
Clinical Practice
8%
English Language
8%
Efficacy Outcomes
8%
Warfarin
8%
Data Extraction
8%
Data Synthesis
8%
Search Terms
8%
Betrixaban
8%
Stroke Prevention
8%
Liver Disease
8%
Patient Care
8%
Health Practices
8%
Literature Search
8%
Cirrhosis
8%
Atrial Fibrillation
8%
Venous Thromboembolic Events
8%
Hepatotoxicity
8%
Human Trials
8%
Bleeding
8%
Pulmonary Embolism
8%
Low Molecular Weight Heparin
8%
Child-Turcotte-Pugh Class
8%
Frequent Monitoring
8%
Venous Thromboembolic
8%
Medicine and Dentistry
Direct Oral Anticoagulant
100%
Chronic Liver Disease
100%
Anticoagulant
25%
Clinical Trial
16%
Thromboembolism
16%
Bleeding
8%
English (Language)
8%
Warfarin
8%
Apoplexy
8%
Betrixaban
8%
Atrial Fibrillation
8%
Liver Cirrhosis
8%
Liver Disease
8%
Patient Care
8%
Pulmonary Embolism
8%
Low Molecular Weight Heparin
8%
Liver Toxicity
8%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
100%
Chronic Liver Disease
100%
Anticoagulant Agent
25%
Clinical Trial
16%
Thromboembolism
16%
Bleeding
8%
Warfarin
8%
Betrixaban
8%
Atrial Fibrillation
8%
Liver Cirrhosis
8%
Hepatotoxicity
8%
Liver Disease
8%
Lung Embolism
8%
Low Molecular Weight Heparin
8%
Cerebrovascular Accident
8%
Nursing and Health Professions
Anticoagulant Agent
100%
Chronic Liver Disease
100%
Thromboembolism
13%
Clinical Practice
6%
Patient Care
6%
Bleeding
6%
Data Extraction
6%
Warfarin
6%
Data Synthesis
6%
Atrial Fibrillation
6%
Lung Embolism
6%
Betrixaban
6%
Liver Disease
6%
Low Molecular Weight Heparin
6%
Liver Toxicity
6%
Liver Cirrhosis
6%
Cerebrovascular Accident
6%